These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22827959)

  • 1. The cobas p 630 instrument: a dedicated pre-analytic solution to optimize COBAS® AmpliPrep/COBAS® TaqMan® system workflow and turn-around-time.
    Vallefuoco L; Sorrentino R; Spalletti Cernia D; Colucci G; Portella G
    J Virol Methods; 2012 Dec; 186(1-2):86-8. PubMed ID: 22827959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantitation of HBV DNA in miniaturized samples: multi centre study to evaluate the performance of the COBAS ® AmpliPrep/COBAS ® TaqMan ® hepatitis B virus (HBV) test v2.0 by the use of plasma or serum specimens.
    Berger A; Gohl P; Stürmer M; Rabenau HF; Nauck M; Doerr HW
    J Virol Methods; 2010 Nov; 169(2):404-8. PubMed ID: 20728470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
    Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
    J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
    Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the automated COBAS AmpliPrep/COBAS TaqMan HIV-1 test on a genetically diverse panel of specimens from China: comparison to the COBAS amplicor HIV-1 monitor test, v1.5.
    Xu S; Song A; Li X; Nie J; Zhang C; Wang Y
    Intervirology; 2010; 53(4):221-8. PubMed ID: 20332651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
    Schumacher W; Frick E; Kauselmann M; Maier-Hoyle V; van der Vliet R; Babiel R
    J Clin Virol; 2007 Apr; 38(4):304-12. PubMed ID: 17329164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus (HBV) genotype determination by the COBAS AmpliPrep/COBAS TaqMan HBV Test, v2.0 in serum and plasma matrices.
    Goedel S; Rullkoetter M; Weisshaar S; Mietag C; Leying H; Boehl F
    J Clin Virol; 2009 Jul; 45(3):232-6. PubMed ID: 19535286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
    Hochberger S; Althof D; Gallegos de Schrott R; Nachbaur N; Röck H; Leying H
    J Clin Virol; 2006 Apr; 35(4):373-80. PubMed ID: 16461000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
    Pyne MT; Mallory M; Hillyard DR
    J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Contamination Risk by the cobas e 602 Serology Module Before Viral Load Testing on the cobas 6800 System.
    Rodriguez PL; McCune S; Sakai L; Engstrom-Melnyk J; Marins E
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S32-S34. PubMed ID: 31895305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of dilution of plasma samples with phosphate buffered saline to eliminate the problem of small volumes associated with children infected with HIV-1 for viral load testing using Cobas AmpliPrep/COBAS TaqMan HIV-1 test, version 2.0 (CAP CTM HIV v2.0).
    Mine M; Nkoane T; Sebetso G; Sakyi B; Makhaola K; Gaolathe T
    J Virol Methods; 2013 Dec; 194(1-2):217-21. PubMed ID: 24025342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
    Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
    J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.
    Ronsin C; Pillet A; Bali C; Denoyel GA
    J Clin Microbiol; 2006 Apr; 44(4):1390-9. PubMed ID: 16597867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS
    Braun P; Drago M; Fanti D; Fleury H; Hofmann J; Izopet J; Kühn S; Lombardi A; Micheli V; Sauné K; Trimoulet P; Whittaker D; Artus A; Rhodes D
    J Clin Virol; 2017 May; 90():18-25. PubMed ID: 28319847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study.
    Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J
    Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pyne MT; Hillyard DR
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):25-30. PubMed ID: 23806661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.